◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY
Home › All stocks › BIO.B › Revenue

Bio-Rad Laboratories, Inc. (BIO.B) Revenue 2021–2025

DATA UPDATED 2026-07-15

Bio-Rad Laboratories, Inc. annual revenue for fiscal 2025 was $2.6 billion, an increase of 0.7% from $2.6 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

BIO.B Annual Revenue

Revenue (annual)2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$2.6B$2.6B$2.7B$2.8B—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BIO.B Quarterly Revenue

Revenue (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$592M$693M$653M$652M$585M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More BIO.B metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All BIO.B financial statements → Interactive BIO.B charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.